Cargando…

Clinical features and (18)F-FDG PET/CT for distinguishing of malignant lymphoma from inflammatory lymphadenopathy in HIV-infected patients

BACKGROUND: It is vital to distinguish between inflammatory and malignant lymphadenopathy in human immunodeficiency virus (HIV) infected individuals. The purpose of our study was to differentiate the variations in the clinical characteristics of HIV patients, and apply (18)F-FDG PET/CT parameters fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Donghe, Zhu, Yunqi, Chen, Yunbo, Zhu, Danhua, Liu, Zhengfeng, Li, Tiancheng, Liu, Yinuo, Zhao, Kui, Su, Xinhui, Li, Lanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327211/ https://www.ncbi.nlm.nih.gov/pubmed/35896979 http://dx.doi.org/10.1186/s12879-022-07640-8

Ejemplares similares

Unusual synchronous liver and brain abscesses infected by rare Aerococcus viridians in a patient with pulmonary arteriovenous malformations on FDG PET/CT: A case report and literature review
por: Chen, Donghe, et al.
Publicado: (2017)

Different Features of (18)F-FAPI, (18)F-FDG PET/CT and MRI in the Evaluation of Extrahepatic Metastases and Local Recurrent Hepatocellular Carcinoma (HCC): A Case Report and Review of the Literature
por: Chen, Donghe, et al.
Publicado: (2022)

Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy
por: Chen, Jia, et al.
Publicado: (2023)

Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on (18)F-FDG PET/CT
por: Smith, Mathew V., et al.
Publicado: (2021)

(18)F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma
por: Kong, Ziren, et al.
Publicado: (2019)

Ability of (18)F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma
por: Ou, Xuejin, et al.
Publicado: (2019)

The role of pre-treatment and mid-treatment 18F-FDG PET/CT imaging in evaluating prognosis of peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS)
por: Zhang, Yafei, et al.
Publicado: (2021)

Kikuchi Disease Manifesting as Multifocal Lymphadenopathy and Splenomegaly: Ultrasonography, CT, and (18)F-FDG PET/CT Findings Mimicking Lymphoma
Publicado: (2020)

Prostatic Adenocarcinoma Masquerading as Generalized lymphadenopathy and Mimicking lymphoma on FDG PET/CT: Diagnosis, Staging, and Evaluation of Therapy Response by FDG PET/CT
por: Joshi, Prathamesh, et al.
Publicado: (2012)

Radiomic Features of (18)F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes
por: Zhou, Yeye, et al.
Publicado: (2021)

Retroperitoneal Fibrosis Masquerading as Para-aortic Lymphadenopathy on F-18 FDG PET/CT in a Patient with Carcinoma Cervix
por: Kashyap, R., et al.
Publicado: (2011)

Concurrent FDG Avid Nasopharyngeal Lesion and Generalized Lymphadenopathy on PET-CT Imaging Is Indicative of Lymphoma in Patients with HIV Infection
por: Liu, Yiyan
Publicado: (2012)

Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F]Choline PET/CT—not only an FDG finding
por: Nawwar, Ayah Adel, et al.
Publicado: (2021)

Role of [18F] FDG PET-CT in detection of COVID-19 vaccine-associated hypermetabolic lymphadenopathy (VAHL) in lymphoma patients: with serologic testing correlation
por: El Sammak, Dena Abd El Aziz, et al.
Publicado: (2023)

Predictive value of intratumoral-metabolic heterogeneity derived from (18)F-FDG PET/CT in distinguishing microsatellite instability status of colorectal carcinoma
por: Zhang, Li, et al.
Publicado: (2023)

COVID-19 vaccine as a cause for unilateral lymphadenopathy detected by 18F-FDG PET/CT in a patient affected by melanoma
por: Avner, Mordechai, et al.
Publicado: (2021)

Diagnostic performance of integrated whole-body (18)F-FDG PET/MRI for detecting bone marrow involvement in indolent lymphoma: Comparison with (18)F-FDG PET or MRI alone
por: Chen, Xuetao, et al.
Publicado: (2023)

Clinical value of (18)F-FDG PET/CT in the management of HIV-associated lymphoma
por: Liu, Qi, et al.
Publicado: (2023)

SUBCLINICAL LYMPHADENOPATHY ON FDG-PET IN LUNG CANCER SCREENING AFTER COVID-19 VACCINE BOOSTER
por: NGUYEN, ANH, et al.
Publicado: (2022)

The Role of (18)F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion
por: Sun, Yajuan, et al.
Publicado: (2016)

Comparison of Nasopharyngeal MR, (18) F-FDG PET/CT, and (18) F-FDG PET/MR for Local Detection of Natural Killer/T-Cell Lymphoma, Nasal Type
por: Guo, Rui, et al.
Publicado: (2020)

FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD
por: Kantarci, Kejal, et al.
Publicado: (2021)

Hypermetabolic Ipsilateral Supraclavicular and Axillary Lymphadenopathy: Optimal Time Point for Performing an (18)F-FDG PET/CT after COVID-19 Vaccination
por: Antwi, Kwadwo, et al.
Publicado: (2022)

18-FDG PET in lung transplantation
por: Algieri, I, et al.
Publicado: (2015)

Myocarditis on (18)FDG-PET imaging
por: Chaaban, Nourhan, et al.
Publicado: (2022)

Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to (18)F-FDG PET/CT
por: Zheng, Dong, et al.
Publicado: (2020)

Habitat Imaging-Based (18)F-FDG PET/CT Radiomics for the Preoperative Discrimination of Non-small Cell Lung Cancer and Benign Inflammatory Diseases
por: Chen, Ling, et al.
Publicado: (2021)

Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma
por: Mistry, Vijay, et al.
Publicado: (2023)

PET probes beyond (18)F-FDG
por: Jiang, Lei, et al.
Publicado: (2014)

Feasibility of (18)FDG PET in the cardiac inflammation
por: Osiecki, Sebastian, et al.
Publicado: (2020)

Delayed (18)F-FDG PET/CT Appearance of Urachal Adenocarcinomas
por: Xu, Lian, et al.
Publicado: (2020)

Application of Dynamic (18)F-FDG PET/CT for Distinguishing Intrapulmonary Metastases from Synchronous Multiple Primary Lung Cancer
por: Lv, Weize, et al.
Publicado: (2022)

Radiological Characteristics of Patients With Anti-MDA5–Antibody-Positive Dermatomyositis in (18)F-FDG PET/CT: A Pilot Study
por: Cao, Heng, et al.
Publicado: (2021)

Prognostic Value of Functional Parameters of (18)F-FDG-PET Images in Patients with Primary Renal/Adrenal Lymphoma
por: Wang, Manni, et al.
Publicado: (2019)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

(18)F-FDG PET/CT imaging features of patients with multicentric Castleman disease
por: Jiang, Yuanyuan, et al.
Publicado: (2021)

Primary nodal anthracosis identified by EBUS-TBNA as a cause of FDG PET/CT positive mediastinal lymphadenopathy
por: Hewitt, Richard J., et al.
Publicado: (2013)

The significance of (18)F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis
por: Zhang, Li-Juan, et al.
Publicado: (2012)

The Role of (18)F-FDG PET/CT in the Evaluation of Peritoneal Thickening of Undetermined Origin
por: Chen, Ruohua, et al.
Publicado: (2016)

(18)FDG-PET/CT Specificity for the Detection of Lymphoma Recurrence in the Tonsils
por: West, Jonathan D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3c68i18l7jula7igruhsvsun4q